H 2 O 2 –Responsive Anticancer Prodrug: Synthesis, Precision Deuteration in Search of In Vivo Metabolites, and Activation Pathway
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.5c01975 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Eron Saxon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry and the Milwaukee Institute for Drug Discovery, University of Wisconsin-Milwaukee, 2000 E. Kenwood Boulevard…. Hauptthemen laut MEDLINE: Prodrugs, Antineoplastic Agents, Hydrogen Peroxide, Nitrogen Mustard Compounds. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, Greater Milwaukee Foundation.
Abstract (Originalsprache)
Boron-based reactive oxygen species (ROS)-activated prodrugs offer a promising strategy for enhancing cancer selectivity, yet their in vivo activation remains poorly defined. We report a novel H2O2-responsive phenylboronic nitrogen mustard prodrug (10a) and its precisely deuterated analogue (10b), designed to elucidate the activation pathway of ROS-responsive agents. These isotopologues differ only in ethyl substituents─hydrogen (10a) versus deuterium (10b)─enabling isotope-resolved tracking of metabolic transformations in vivo. Co-administration of 10a and 10b in triple-negative breast cancer xenograft mice identified two metabolites, providing the first definitive in vivo evidence of oxidative deboronation as the primary activation mechanism. Prodrug 10a exhibited H2O2-inducible DNA-alkylating activity, selectively inhibited the proliferation of high ROS-expressing MDA-MB-468 cancer cells over nonmalignant MCF-10A cells, markedly suppressed tumor growth without observable toxicity. This study highlights precision deuteration as a mechanistic probe and establishes a platform for rational design and optimization of boron-based anticancer prodrugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry and the Milwaukee Institute for Drug Discovery, University of Wisconsin-Milwaukee, 2000 E. Kenwood Boulevard, Milwaukee, Wisconsin 53211, United States.
- Department of Chemistry, Marquette University, 1414 W Clybourn St, Milwaukee 53233, Wisconsin, United States.
- Department of Chemistry, University of Tennessee, Knoxville, Tennessee 37996, United States.
ORCID-Profile: Xiaohua Peng
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- Greater Milwaukee Foundation
- National Institutes of Health
- National Institute of General Medical Sciences
- UWM Discovery and Innovation
- UWM Research Foundation Bradley Catalyst Grant Program
Zitieren
APA
Saxon, E., Stambekova, D., Ponnamperumage, T. N. F., Clark, J. R., & Peng, X. (2025). H 2 O 2 –Responsive Anticancer Prodrug: Synthesis, Precision Deuteration in Search of In Vivo Metabolites, and Activation Pathway. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c01975
Vancouver
Saxon E, Stambekova D, Ponnamperumage TNF, Clark JR, Peng X. H 2 O 2 –Responsive Anticancer Prodrug: Synthesis, Precision Deuteration in Search of In Vivo Metabolites, and Activation Pathway. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.5c01975
BibTeX
@article{Saxon2025,
author = {Saxon, Eron and Stambekova, Dana and Ponnamperumage, Thilini Nimasha Fernando and Clark, Joseph R and Peng, Xiaohua},
title = {H 2 O 2 –Responsive Anticancer Prodrug: Synthesis, Precision Deuteration in Search of In Vivo Metabolites, and Activation Pathway},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.5c01975}
}
EUVIMED